Compare Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) vs Emerson Electric Co. (EMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio-Rad Laboratories, Inc. Class A Common Stock vs Emerson Electric Co. — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $298.3 (market cap $8.04B), while Emerson Electric Co. trades at $136.73 (market cap $76.22B). The key difference: Emerson Electric Co. is far larger — about 9.5× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and Emerson Electric Co. pays a 1.63% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | EMR | |
|---|---|---|
Market Cap | $8.04B | $76.22B |
Sector | Health | Industrials |
52-Week High | $339.75 | $161.69 |
52-Week Low | $241.71 | $123.30 |
Enterprise Value | $7.85B | $88.49B |
Dividend Yield | — | 1.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BIO trades at $297.58, up 0.5% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $305. The stock shows strong profitability with a 51.87% gross margin and positive net income of $760M in 2025, though recent quarters have seen EPS misses. Cash flow from operations remains robust at $532M, supporting financial stability.
Outlook is cautiously optimistic with analyst support, but risks include earnings volatility and high P/E valuation. The company's return to profitability and solid balance sheet provide a foundation for growth, though investors should monitor execution against future earnings expectations and competitive pressures in the biotech sector.
Emerson Electric (EMR) trades at $135.38, down 2.52% on the day, with a bearish technical signal and mixed earnings history. The stock shows moderate valuation ratios (P/E 31.34, P/S 4.17) and stable profitability (net margin 13.35%). Recent news highlights upcoming Q3 2026 earnings and dividend activity, while cash flow trends indicate operational strength but net outflows.
The outlook is cautiously optimistic with a consensus price target of $157.60 (16.4% upside), supported by analyst buy ratings (51.2%). Key risks include volatile cash flows and competitive pressures in manufacturing electronics. Earnings growth and sector momentum remain catalysts for potential appreciation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bio-Rad Laboratories, Inc. Class A Common Stock
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →About Emerson Electric Co.
Emerson Electric is a multi-industrial conglomerate that operates under two business platforms: automation solutions and commercial and residential solutions. The latter is further subdivided into two operating segments: climate technologies, which sells HVAC and refrigeration products and services as well as tools and home products, which sells tools and compressors, among other products and services. Commercial and residential solutions boasts several household brands, including Copeland and RIDGID. Automation solutions is most known for its process manufacturing solutions, which consists of measurement instrumentation, as well as valves and actuators, among other products and services. Roughly half of the firm's geographic sales take place in the United States.
Read more on EMR →
